Clinical Trial Update: Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis

View source ↗

Summary

This document provides an update on a clinical trial evaluating the incidence of relapses in patients with progressive multiple sclerosis treated with high-dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• BIotiN (biotin)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Progressive Multiple Sclerosis | Status: UNKNOWN